The isolation of N10 formylfolic acid' from natural materials has been reported by several groups of workers (Rauen et al., 1952; Rauen and Jaenicke, 1953; Greenberg, 1954a; Silverman et al., 1954) . It was concluded that the compound had been derived either from the degradation of a labile intermediate involved in the conversion of a bound (microbiologically inactive) form of folic acid in liver to citrovorum factor (CF) or from a biosynthetically prepared transformylation cofactor. These observations have taken on added significance since Greenberg has shown recently that N10 formyltetrahydrofolic acid or a closely related compound (anhydrocitrovorum factor in which the one carbon unit is linked in a 5 to 10 bridge) can donate its formyl group to 4-amino-5-imidazolecarboxamide ribotide (Greenberg, 1954b and per8onal communication) . Dr. Greenberg kindly supplied us with several synthetic samples of such reduced and formylated derivatives of folic acid. These possessed varying degrees of citrovorum factor activity which disappeared if the samples were stored for several hours at room temperature or were subjected to autoclaving. The lability of the active samples suggested that if such forms occurred naturally they might not have been detected because of their great instability. We undertook the search for such compounds and wish to describe the occurrence and some properties of a labile compound in urine which possesses growth activity for Leuconostoc citrovorum. This factor differs from CF in that it is destroyed during normal autoclaving procedures in the absence of reducing agents.
METHODS
The microbiological procedures for the tubegrowth assays employing Streptococcus faecalis strain R and L. citrovorum strain 8081 (Pediococcum sp., Felton and Niven, 1953) have previously 1 The structural formulae of the derivatives of folic acid discussed in this report are all described in May et al., 1951. been described (Keresztesy and Silverman, 1950) . The media were supplemented to contain 2,g each of pyridoxamine and pyridoxal per 10 ml. Calcium citrovorum factor, isolated from horse liver, was used as the reference standard (Keresztesy and Silverman, 1951) .
A freshly prepared solution of ascorbic acid was used in each experiment. The solution was adjusted to pH 6.0 with potassium hydroxide and contained 100 mg of ascorbic acid per ml.
Urine specimens employed were obtained from subjects within 3 to 5 hr after they had ingested 5-or 15-mg doses of folic acid (Lederle "folvite"). The specimens of urine were stored at -10 C immediately after voiding.
Unless specified otherwise, samples for assay were sterilized in the basal medium by autoclaving for 10 min at 12 lb steam presure. sterilized by ifitration at 0 C were added aseptically to previously autoclaved media which, after cooling, received 2 mg of freshly prepared potassium ascorbate per tube (10 ml).
The conversion of the labile compound to heat stable CF during autoclaving in ascorbic acid 1.0-ml samples were stored at pH values indicated for 2 hr at 23 C, the pH was adjusted to 6.0, 50 mg of ascorbic acid was added and the samples were autoclaved for 30 min at 12 lb pressure. They were then diluted to 50 ml for assay. The urine specimen when assayed directly (ascorbic acid absent) yielded a value of 45 mug citrovorum factor/ml. occurred equally well over a wide pH range. When the pH of the urine-ascorbic acid solutions were varied from 4.0 to 11.0, essentially the same values were obtained.
The amount of CF activity found in a speci- 0.1 N NaOH or at pH 6.0 to 7.0 to autoclaving temperatures, yet is inactivated when stored aerobically at 23 C and at a pH of 3.6 or below (Keresztesy and Silverman, 1950) . Swendseid et al. (1952) have reported that, when incubated with folic and ascorbic acids, leukocytes give rise to a product that supports the growth of L. citrovorum. This product, designated tentatively as "hemofolin," was characterized in part by a growth response which, relative to CF, increased with the sample size. The growth response curve to CF was parabolic, whereas that to "hemofolin" was S-shaped. A similar response can be obtained with "labile" CF. One-ml portions of a urine specimen and 50 mg of ascorbic acid at pH 6.0 were heated at 100 C for 0 to 120 min. Each sample was diluted to 50 ml and aliquots were added to the basal medium. The latter was then sterilized by autoclaving for 10 min at 12 lb pressure. Some of the results are shown in figure 1 and table 6. The growth response to the sample not subjected to prebeating resembled that for "hemofolin" in that the values found (1.75 to 4.50 mpg/ml calculated from figure 1) increased with the size of the aliquot employed (0.2 to 1.0 ml). If, however, the sample and ascorbic acid were heated for 120 min at 100 C, the growth response to the sample paralleled that of CF and gave a consistent value of 5.9 to 6.0 m,g/ml. The same sample autoclaved with ascorbic acid for 30 min at 12 lb pressure gave an identical response curve. Samples heated at 100 C for intervals under 120 min gave response curves that fell between the two shown in figure 1.
Our data suggest that the appearance of progressively higher yields of CF activity was due to an increase in the amount of ascorbic acid carried over into the assay tubes as the size of the sample was increased from 0.2 to 1.0 ml. Five hundred millilters of urine which, by assay, contained approximately 168 ,g of "labile" CF were adjusted to pH 3.0 with HCI. One gram of charcoal ("darco" KB) was added and the mixture was stirred for 1 hr at 23 C. The charcoal was recovered by filtration and washed with water. The charcoal was then eluted by stirring for 15 min with 150 ml of eluting solvent (75 parts of ethanol, 20 parts of water, and 5 parts of 28 per cent NH4OH by volume). The eluate was separated by filtration and the eluting procedure was repeated twice. The three eluates were combined, concentrated to 25 ml in vacuo and stored at 0 C for 3 days. An insoluble precipitate was then rejected and a water wash of the precipitate (5 ml) and supernatant solutions were combined, concentrated to 7.0 ml and stored 18 hr at 0 C. A small dark precipitate was rejected and the supernatant fluid was concentrated to 1.0 ml and applied in an 18-in-long band on Schleicher & Schull 470A paper and chromatographed as previously described for the isolation of Nb0 formylfolic acid from liver (Silvermanet al., 1954) .
In the first passage on paper S. faecalis activity was found in a blue fluorescent zone about 0.5 in from the origin and 1.5 in wide. Several other blue fluorescing components, which posseed no microbiological growth activity, were also present. The active material was eluted with water and the eluate (containing 150 jRg S. faecaUis active material) concentrated to 1.0 ml and the chromatography was repeated on a section of paper 10 inches wide. The sample was resolved into 4 fluorescent components, three of which contained S. faecalis activity. The activity was asociated with a narrow band X in from the origin (10 ,ug) and 2 overlapping bands (125 ,ug) between % and 2X in from the origin.
A third blue fluorescent band, microbiologically inactive, was present at 3% inches.
The two overlapping bands were eluted with water and the eluates combined and concentrated to 1 ml. The pH was adjusted to 4.0 and 5 ml dry butanol added. The butanol solution was placed on the top of a Sulka-flok column (8 by 1 in in water-saturated butanol). One hundred eighty milliliters of water-saturated butanol was passed through the column and yellow-pigmented material and an inactive blue fluorescent material which moved with this solvent were discarded. The column was now eluted with 5 per cent acetic acid in water-saturated butanol. Five-ml fractions were taken. All of the biological activity was found in fractions %48 to %60. These were combined, concentrated in vacuo to 1 ml and chromatographed on an 8-in section of S & S 0470A paper. A major blue fluorescent band was obtained at 2 in above the origin. The major band was rechromatographed under the same conditions. Only 1 blue fluorescent band appeared on paper which, after elution, possessed a spectrum in the ultraviolet characteristic of N10 formylfolic acid (peaks at 260 and 365 mu); moved at rates identical with authentic (synthetic) N10 formylfolic acid on paper in butanolacetic acid (5 per cent) and 5 per cent Na2HPO4 faecali8 (24 Ag in the final eluate).
DISCUSSION
The occurrence of labile compounds having CF activity has been recorded recently by Deodhar et al. (1955) and Nichol et al. (1955) . The product of Deodhar et al. arose during the anaerobic incubation of a liver enzyme preparation containing serine and 5,6,7,8-tetrahydrofolic acid. The product of Nichol et al. (1955) was derived during anaerobic incubation of folic acid with cells of S. faecali8 (A-methopterinresistant) . The available stability data suggest that the labile products from liver, S. faecaiU A and urine are identical or closely related. The occurrence of a compound in both urine and S. faecalis incubates (Nichol et al., 1955) that possessed the properties of Nb0 formylfolic acid is consistent with the view that the labile compound is a reduced derivative of Nb°formylfolic acid.
That the N10 formylfolic acid is derived as a degradation product in urine is suggested by the occurrence at one stage in its separation of three blue fluorescent bands on paper which contained S. faecali8 activity. Since only one of these appeared to be N10 formylfolic acid, the other two bands could represent stages in the degradation of the labile compound to its oxidized derivatives. Indirect evidence that the "labile" CF is a reduced N10 formylfolic acid derivative is offered by the studies of May et al. (1951) . They pointed out that ascorbic acid was extremely effective in preventing the oxidation of N10 formyltetrahydrofolic acid during its conversion by heat to CF (5-formyl derivative) and in addition a material active for L. citrovorum could be obtained by autoclaving N10 dihydroformylfolic acid in a neutral solution containing ascorbic acid. In viewing the possibility that "labile" CF is a derivative of NI0 formyltetrahydrofolic acid, it must be borne in mind that under anaerobic conditions the latter is in equilibrium with anhydrocitrovorum factor in which the one carbon unit is linked in a 5 to 10 bridge (May et al., 1951) . Identity of the CF active materials from liver, S. faecalis, and urine rests on the eventual isolation of the labile compound from these sources.
The data on the quantitative relationship between CF (5-formyltetrahydrofolic acid) and "labile" CF in urine are significant. They suggest that the bulk of the biologically active CF exis in the form of the labile factor and must be considered in all excretion studies. Hitherto, the "labile" CF had been destroyed by the conventional procedure of autoclaving the sample in the assay medium. Studies in which such procedures were employed should be re-evaluated. In this connection attention should be called to the observations of Broquist et al. (1951) , Foley and Haley (1953), and Steinnan et al. (1954) . They demonstrated that under suitable test conditions tetrahydro-or dihydrofolic acid could replace CF for L. citrovorum and the Reiter treponeme. The implications of these observations were not fully appreciated by those concerned with the occurrence of folic acid derivatives in biological systems.
